HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 232 filers reported holding HORIZON PHARMA PLC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $24,843,000 | +34.4% | 939,973 | -0.6% | 2.91% | +37.5% |
| Q4 2018 | $18,486,000 | +3.0% | 946,060 | +3.2% | 2.11% | +17.5% |
| Q3 2018 | $17,956,000 | -33.6% | 917,051 | -43.8% | 1.80% | -35.0% |
| Q2 2018 | $27,029,000 | -5.2% | 1,632,212 | -18.7% | 2.77% | -21.3% |
| Q1 2018 | $28,502,000 | -0.1% | 2,007,212 | +2.7% | 3.51% | -8.9% |
| Q4 2017 | $28,542,000 | -25.1% | 1,954,912 | -35.0% | 3.86% | -20.8% |
| Q3 2017 | $38,127,000 | +32.6% | 3,006,862 | +24.1% | 4.87% | +17.9% |
| Q2 2017 | $28,750,000 | +11.1% | 2,422,090 | +38.3% | 4.13% | +0.7% |
| Q1 2017 | $25,885,000 | +128.5% | 1,751,322 | +150.2% | 4.10% | +88.8% |
| Q4 2016 | $11,326,000 | -99.8% | 700,000 | +91.8% | 2.17% | +106.6% |
| Q3 2016 | $6,617,450,000 | +108489.6% | 365,000 | -1.4% | 1.05% | -2.9% |
| Q2 2016 | $6,094,000 | +83.9% | 370,000 | +85.0% | 1.08% | +64.4% |
| Q1 2016 | $3,314,000 | +4.7% | 200,000 | +37.0% | 0.66% | +37.7% |
| Q4 2015 | $3,164,000 | – | 146,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |